Search
for
Sort by
Research 30 of 531
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- Finasteride- and dutasteride-related suicidal ideation
- Suicidal ideation in patients undergoing treatment with 5α-reductase inhibitors
- Suicidal ideation with finasteride but not dutasteride
- US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know?
- Systematic review: depression, suicidal ideation with finasteride
- Finasteride linked with suicidal ideation/self-harm
- Suicidal behaviors (suicidal ideation, suicide attempt and completed suicide) in patients treated with finasteride for hair loss: Results from the U.S. FDA Adverse Event Reporting System (FAERS) database
- Finasteride-related depression and suicidal ideation
- Finasteride-related suicidal ideation reported to Lareb
- Finasteride: potential risks of suicidal ideation and self-injury
- Risk of finasteride-related suicidal ideation
- Finasteride-related self-harm and suicidal ideation
- Finasteride, dutasteride: potential risk of suicidal ideation
- Finasteride 1 mg in alopecia: sexual dysfunction, suicidal ideation. Providing balanced information to male patients is key.
- Dipyridamole-Associated Shock and Pulmonary Edema; Oxcarbazepine-Induced Resistant Ventricular Fibrillation; Finasteride-Induced Pseudoporphyria; Suicidal Ideation Associated with Asenapine; Rediscovering Adverse Anticholinergic Effects; Prevalence of Adverse Drug Events in Ambulatory Care
- Post-finasteride syndrome: a surmountable challenge for clinicians
- Risk of Depression Associated With Finasteride Treatment
- Ongoing Concerns Regarding Finasteride for the Treatment of Male-Pattern Androgenetic Alopecia
- Oral Presentations: Abstracts of the Urological Society of Australia and New Zealand Annual Scientific Meeting, 25–28 February 2023, Melbourne, Australia
- 76976 Association of Depression with Finasteride Stratified by Dosage and Diagnosis: A Retrospective Cohort Study Using the TriNetX Database
- Post-finasteride syndrome: pharmacists must lead the conversation on patient safety
- Finasteride Use: Evaluation of Depression and Suicide Risk
- Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Sun behaviors and quality of life after first cutaneous melanoma diagnosis
- Sun protection policies and behaviors among U.S. child care centers
- Sunscreen: Cosmetic or medical therapy?
- Association of 5-α reductase inhibitors and sexual dysfunction: A RADAR report
- En pacientes jóvenes, el uso de finasteride podría asociarse con mayor riesgo de ansiedad, depresión y eventos adversos relacionados con el suicidio
- Finasteride